September 29 Summit Offers Complimentary Registration for All
The ISPOR-FDA Summit 2020 on Patient-Preference Information in Medical Devices is now virtual. Brett Hauber, Senior Economist and VP of Health Preference Assessment at RTI Health Solutions, will be speaking at the following session during the Summit on September 29, 2020
Session 1: Introduction to and Background of Patient-Preference Information (PPI)
This session will provide an overview of PPI and the various terms referenced in this field. This will include a discussion on the fundamentals of how PPI differs from other types of patient-provided information and the different types of regulatory decisions that can be informed by PPI. A review of current regulatory documents that involve PPI, as well as an explanation of the quality measures considered by CDRH will be presented.
Speakers: Anindita (Annie) Saha, Brett Hauber, PhD
Session 2: Case Studies for Use of PPI in Medical Device Decision-Making Processes
11:30 am - 1:00 pm
This session will be comprised of 4 separate case study presentations involving PPI. The cases will offer insights into the reason or indication for the PPI study, problems/challenges that were successfully addressed or unsuccessfully resolved, and a summary of the overall outcomes and lessons learned. Time for audience Q/A will follow at the end of the session.
Speakers: Dan Harfe; Barry Liden; Christine Poulos, PhD; Todd Snell, MBA; Kimberly Brown-Smith, PhD, MD; Michelle Tarver, MD, PhD
Registration for the Summit is complimentary. Prior registrants (for the previously scheduled event on March 31) do need to re-register for the new, completely virtual event now scheduled for September 29.
A pre-event webinar co-presented by Brett Hauber, “Patient-Preference Information—What It Is and What It Is Not,” is currently available on demand and provides a primer on the topic of patient-preference information. The webinar is recommended for Summit participants, is complimentary, and is available to be viewed by all (both registrants and non-registrants).
For additional details, including the program schedule and speaker information, please visit the ISPOR-FDA Summit 2020 website here.